ErSO-TFPy (TEQ103) is an ERalpha+ tumor cell inhibitor with low nanomolar cytotoxic activity against ERalpha+ breast cancer cells. ErSO-TFPy activates the sodium channel TRPM4, causes an imbalance of intracellular calcium and sodium ions. ErSO-TFPy dysregulates calcium homeostasis in ERalpha+ tumor cells, triggers the anticipatory unfolded protein response, and induces rapid immune cell-independent necrotic cell death. ErSO-TFPy can be used for the research of estrogen receptor alpha positive breast cancer[1][2].
Molekulargewicht:
434.31
Reinheit:
99.33
CAS Nummer:
[3035547-78-2]
Formel:
C19H13F7N2O2
Target-Kategorie:
Sodium Channel,TRP Channel
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten